| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0041 | 0.9 |